Why Blood Sugar Control After 50 Is Different in Ireland — CGM Devices, Scheme Coverage, Private Clinics and What It Costs in 2026
After 50, blood sugar levels become harder to manage — and in Ireland, knowing your options matters more than ever. From FreeStyle Libre and Dexcom G7 available at Boots and Lloyds Pharmacy, to what the Long Term Illness Scheme, GMS, and Drug Payment Scheme actually cover — the difference between paying full price and getting support can be hundreds of euros per month. Private endocrinologists in Dublin, Cork, and Galway, structured HSE programmes, and A1C testing costs compared — here is what Irish adults over 50 should review before their next GP appointment in 2026.
This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.
After 50, the body’s ability to regulate glucose can shift in ways that are not always obvious. Hormonal changes, reduced physical activity, and the natural decline in insulin sensitivity mean that blood sugar levels can become harder to predict. In Ireland, these physiological changes intersect with a healthcare system that offers some publicly funded supports alongside a growing private sector — and understanding both is increasingly important for older adults.
FreeStyle Libre vs Dexcom G7 in Ireland After 50
Continuous glucose monitors, or CGMs, have transformed how people track blood sugar without constant finger-prick tests. The two most widely discussed options in Ireland are the FreeStyle Libre (particularly the Libre 2 and Libre 3 models) and the Dexcom G7. Both offer real-time glucose readings, but they differ in sensor wear time, app functionality, and cost structure. The FreeStyle Libre sensors typically cost around €50–€60 per sensor and last 14 days, while the Dexcom G7 sensor lasts 10 days and is priced at roughly €80–€90 per sensor without scheme support. For people over 50 managing type 1 diabetes or insulin-treated type 2 diabetes, CGM use has been shown to improve glucose time-in-range outcomes significantly. The choice between devices often comes down to personal preference, phone compatibility, and whether your condition qualifies for public funding.
| Device | Provider | Sensor Duration | Estimated Monthly Cost (Private) |
|---|---|---|---|
| FreeStyle Libre 3 | Abbott | 14 days | €100–€120 |
| Dexcom G7 | Dexcom | 10 days | €240–€270 |
| FreeStyle Libre 2 | Abbott | 14 days | €100–€115 |
Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.
Long Term Illness Scheme, GMS and Drug Payment Scheme
Several Irish public health schemes can substantially reduce the cost of blood sugar monitoring for adults over 50. The Long Term Illness (LTI) Scheme covers CGM supplies for people with type 1 diabetes, meaning qualifying individuals receive devices and sensors at no cost. The General Medical Services (GMS) scheme, available to medical card holders, also covers a range of diabetes-related medications and monitoring supplies. For those who do not hold a medical card, the Drug Payment Scheme (DPS) caps monthly out-of-pocket spending on approved medicines and devices at €80 per month per household. It is worth noting that CGM coverage under public schemes in Ireland has historically been more accessible for type 1 diabetes than for type 2, though this is an evolving area. Checking directly with the HSE or your GP regarding your specific eligibility is always recommended.
Private Endocrinologist vs HSE Waiting List in Ireland
Accessing an endocrinologist through the public HSE system can involve waiting times of several months, particularly in larger urban centres. For adults over 50 with concerns about insulin resistance, prediabetes or poorly controlled type 2 diabetes, this delay can feel significant. Private consultations with endocrinologists in Dublin, Cork, and Galway are available, with initial consultation fees typically ranging from €150 to €250. Follow-up appointments tend to cost between €100 and €180. Clinics such as the Bon Secours Health System, Blackrock Clinic in Dublin, and Galway Clinic offer endocrinology services privately, and referral from a GP is usually still required. Whether going private is worthwhile depends on the urgency of your situation and your financial circumstances.
VHI, Laya Healthcare and Axa Health — CGM and Diabetes Cover
Private health insurance in Ireland varies considerably in what it covers for diabetes management and CGM devices. VHI, Laya Healthcare, and Axa Health all offer plans that include outpatient consultant cover, but CGM device reimbursement is less standardised. Some higher-tier plans may include partial cover for devices or outpatient diabetes-related diagnostics, while entry-level plans typically do not. It is important to review your specific policy document or contact your insurer directly to confirm what is covered. Insurance plan details can change annually, and what applied in previous years may not reflect 2026 coverage.
A1C Test, Prediabetes and Insulin Resistance in Ireland
For many Irish adults over 50, a routine blood test revealing elevated HbA1c (A1C) levels is the first sign that blood sugar management needs attention. A GP can request an A1C test as part of a standard blood panel, and it is typically covered under GMS for medical card holders. Privately, an A1C test costs approximately €20–€50 depending on the laboratory. Prediabetes, defined as an A1C between 5.7% and 6.4%, is increasingly common in older adults and does not automatically require medication — but it does call for lifestyle review and monitoring. Speaking openly with your GP about insulin resistance risk, family history, and lifestyle factors is a practical first step. Private testing through services such as Medinol, Spectra Laboratory, or Affidea is available across multiple Irish locations.
Blood sugar control after 50 in Ireland involves navigating a mix of public entitlements, private options, and evolving technology. Having a clear picture of what schemes you qualify for, what devices suit your needs, and what private care realistically costs puts you in a much stronger position to make informed decisions alongside your healthcare team.
